Open AccessPhysical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator
Author(s) -
Burch Ashley E.,
D'Souza Benjamin,
Gimbel J. Rod,
Rohrer Ursula,
Masuda Tsuyoshi,
Sears Samuel,
Scherr Daniel
Publication year - 2020
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.23288
Subject(s) - medicine , ventricular fibrillation , ventricular tachycardia , cardiology , defibrillation , implantable cardioverter defibrillator , ejection fraction , shock (circulatory) , defibrillation threshold , incidence (geometry) , heart failure , physics , optics
The utility of accelerometer‐based activity data to identify patients at risk of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) has not previously been investigated. The aim of the current study was to determine whether physical activity is associated with manifesting spontaneous sustained VT/VF requiring emergent defibrillation in patients with an ejection fraction of ≤35%. Methods Patients consecutively prescribed a wearable cardioverter defibrillator (WCD) from April 2015 to May 2018 were included. Shock data and 4 weeks of physical activity data, beginning with the first week of WCD wear, were analyzed. Results Based on the ROC curve outcome generated from 4057 patients, average daily step count during the first week accurately predicted those patients with sustained VT/VF compared to those without (shocked (n = 81) vs nonshocked (n = 3976) area under the curve, c‐index = 0.71, 95% CI = 0.65‐0.77, P < .001). An average cutoff of 3637 daily steps during week 1 separated the groups. Patients who averaged fewer than 3637 steps per day during the first week of WCD use were 4.3 times more likely to experience a shock than those who walked more than 3637 steps per day (OR = 4.29, 95% CI = 2.58‐7.15, P < .001). Discussion Average daily step counts are lower in WCD patients who manifest spontaneous VT/VF. Whether these findings represent a causal or correlational relationship, future studies to encourage a minimum daily step count in high‐risk patients may impact the incidence of sustained VT/VF.